BioXcel Therapeutics, Inc.
NASDAQ:BTAI
Overview | Financials
Company Name | BioXcel Therapeutics, Inc. |
Symbol | BTAI |
Currency | USD |
Price | 0.351 |
Market Cap | 17,424,742 |
Dividend Yield | 0% |
52-week-range | 0.3 - 4.17 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Vimal D. Mehta Ph.D. |
Website | https://www.bioxceltherapeutics.com |
An error occurred while fetching data.
About BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD